Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
EU Slaps Meta With €798 Million Fine
EU Fines Meta $840 Million Over Classified Ads Business
An EU commission alleged that Meta leveraged its dominance in social networking to gain an unfair advantage in online classified ads.
EU slaps Meta with a nearly 800 million euro fine for engaging in ‘abusive’ Marketplace practices
European Union regulators hit Facebook parent Meta with a fine of nearly 800 million euros on Thursday for what it calls “abusive practices” involving its Marketplace online classified ads business.
EU issues €797M antitrust fine to Meta over Facebook Marketplace
Launched in 2016, Facebook Marketplace enables users of Meta’s flagship social network to buy and sell goods. The European Commission, the EU’s executive arm, launched a probe into the service in 2021 over concerns it may harm competition. Today’s fine is the culmination of that probe.
EU regulator backs Eisai-Biogen Alzheimer's drug
European committee takes a second look at Alzheimer’s drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug.
EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection
The European Union's drugs regulator on Thursday recommended approval for Eisai and Biogen's Leqembi in some patients with early Alzheimer's disease, nearly four months after it first rejected the treatment.
EU regulator reverses decision to block Alzheimer's drug lecanemab
The European Union's drugs regulator reversed its decision to block the Alzheimer's drug lecanemab, a treatment aimed at slowing cognitive decline in patients. In July, the Amsterdam-based European Medicines Agency (EMA) denied recommending approval of the drug made by Eisai and Biogen because it considered the risks - especially bleeding and swelling in the brain - to be greater than the potential benefits in a broad population.
RBC Ukraine on MSN
11m
EU to make first-ever joint weapons purchase, part of which will go to Ukraine
For the first time in its history, the European Commission has approved funding for the joint purchase of weapons by EU ...
Politico Europe
5h
Here’s the timeline for the new European Commission
European Parliament lawmakers have put Ursula von der Leyen’s 26 commissioner nominees through the wringer for nearly 80 ...
1d
EU top jobs hearings stalled by political infighting over hard right alliances
The socialists accused the EPP leadership of “irresponsible behavior” by working with the Spanish populist party Vox to ...
RBC Ukraine on MSN
3h
European Commission approves allocation of over €4 billion to Ukraine under Ukraine Facility
The European Commission has approved the allocation of 4.1 billion euros to Ukraine. These funds will be provided under the ...
about.fb
8h
Our Response to the European Commission’s Decision on Facebook Marketplace
The European Commission’s decision provides no evidence of competitive harm to rivals or any harm to consumers.
12h
EU says Booking must now comply with Digital Markets Act
The European Commission on Thursday said hotel reservation website Booking.com must now comply with strict EU obligations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Meta
Facebook
Feedback